743 related articles for article (PubMed ID: 17695274)
21. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
22. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
23. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
24. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
25. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
26. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
27. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
[TBL] [Abstract][Full Text] [Related]
28. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
29. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
30. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
31. A mathematical analysis of the dynamics of prion proliferation.
Greer ML; Pujo-Menjouet L; Webb GF
J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
[TBL] [Abstract][Full Text] [Related]
32. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
33. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
34. [Systematic review of the therapeutics for prion diseases].
Sakaguchi S
Brain Nerve; 2009 Aug; 61(8):929-38. PubMed ID: 19697882
[TBL] [Abstract][Full Text] [Related]
35. The brain to gut pathway: a possible route of prion transmission.
Lawson VA; Furness JB; Klemm HM; Pontell L; Chan E; Hill AF; Chiocchetti R
Gut; 2010 Dec; 59(12):1643-51. PubMed ID: 21071583
[TBL] [Abstract][Full Text] [Related]
36. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
37. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
[TBL] [Abstract][Full Text] [Related]
38. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
39. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
40. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
